Annual Accounts Receivable
$141.80 M
+$39.10 M+38.07%
31 December 2023
Summary:
Emergent BioSolutions annual accounts receivable is currently $141.80 million, with the most recent change of +$39.10 million (+38.07%) on 31 December 2023. During the last 3 years, it has fallen by -$30.90 million (-17.89%). EBS annual accounts receivable is now -39.40% below its all-time high of $234.00 million, reached on 31 December 2018.EBS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$102.60 M
-$18.10 M-15.00%
30 September 2024
Summary:
Emergent BioSolutions quarterly accounts receivable is currently $102.60 million, with the most recent change of -$18.10 million (-15.00%) on 30 September 2024. Over the past year, it has dropped by -$54.00 million (-34.48%). EBS quarterly accounts receivable is now -59.19% below its all-time high of $251.40 million, reached on 30 September 2019.EBS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.1% | -34.5% |
| 3 y3 years | -17.9% | -47.9% |
| 5 y5 years | -39.4% | -59.2% |
EBS Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -38.5% | +38.1% | -57.0% | at low |
| 5 y | 5 years | -39.4% | +38.1% | -59.2% | at low |
| alltime | all time | -39.4% | +5504.7% | -59.2% | +3955.3% |
Emergent BioSolutions Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $102.60 M(-15.0%) |
| June 2024 | - | $120.70 M(-37.8%) |
| Mar 2024 | - | $194.10 M(+36.9%) |
| Dec 2023 | $141.80 M(+38.1%) | $141.80 M(-9.5%) |
| Sept 2023 | - | $156.60 M(-34.3%) |
| June 2023 | - | $238.50 M(+123.9%) |
| Mar 2023 | - | $106.50 M(+3.7%) |
| Dec 2022 | $102.70 M(-55.4%) | $102.70 M(-13.7%) |
| Sept 2022 | - | $119.00 M(-0.8%) |
| June 2022 | - | $119.90 M(+4.1%) |
| Mar 2022 | - | $115.20 M(-50.0%) |
| Dec 2021 | $230.50 M(+33.5%) | $230.50 M(+17.0%) |
| Sept 2021 | - | $197.00 M(-6.3%) |
| June 2021 | - | $210.30 M(+56.9%) |
| Mar 2021 | - | $134.00 M(-22.4%) |
| Dec 2020 | $172.70 M(-24.0%) | $172.70 M(+4.0%) |
| Sept 2020 | - | $166.00 M(-17.9%) |
| June 2020 | - | $202.20 M(+69.3%) |
| Mar 2020 | - | $119.40 M(-47.5%) |
| Dec 2019 | $227.30 M(-2.9%) | $227.30 M(-9.6%) |
| Sept 2019 | - | $251.40 M(+40.1%) |
| June 2019 | - | $179.50 M(+100.3%) |
| Mar 2019 | - | $89.60 M(-61.7%) |
| Dec 2018 | $234.00 M(+96.8%) | $234.00 M(+204.1%) |
| Sept 2018 | - | $76.95 M(-59.4%) |
| June 2018 | - | $189.49 M(+55.2%) |
| Mar 2018 | - | $122.09 M(+2.7%) |
| Dec 2017 | $118.90 M(+31.5%) | $118.90 M(-8.1%) |
| Sept 2017 | - | $129.36 M(+26.2%) |
| June 2017 | - | $102.51 M(-20.0%) |
| Mar 2017 | - | $128.08 M(+41.6%) |
| Dec 2016 | $90.44 M(-5.5%) | $90.44 M(+29.9%) |
| Sept 2016 | - | $69.63 M(+4.3%) |
| June 2016 | - | $66.75 M(-4.0%) |
| Mar 2016 | - | $69.56 M(-27.3%) |
| Dec 2015 | $95.73 M | $95.73 M(+67.8%) |
| Sept 2015 | - | $57.04 M(-42.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $99.72 M(+55.7%) |
| Mar 2015 | - | $64.06 M(+60.4%) |
| Dec 2014 | $39.95 M(-12.7%) | $39.95 M(-9.4%) |
| Sept 2014 | - | $44.11 M(-43.6%) |
| June 2014 | - | $78.27 M(+24.4%) |
| Mar 2014 | - | $62.94 M(+37.5%) |
| Dec 2013 | $45.76 M(-39.9%) | $45.76 M(+52.1%) |
| Sept 2013 | - | $30.09 M(-44.7%) |
| June 2013 | - | $54.37 M(-13.7%) |
| Mar 2013 | - | $62.96 M(-17.3%) |
| Dec 2012 | $76.16 M(+38.0%) | $76.16 M(+345.7%) |
| Sept 2012 | - | $17.09 M(-63.5%) |
| June 2012 | - | $46.81 M(+7.2%) |
| Mar 2012 | - | $43.65 M(-20.9%) |
| Dec 2011 | $55.19 M(+40.3%) | $55.19 M(+12.6%) |
| Sept 2011 | - | $48.99 M(+3.7%) |
| June 2011 | - | $47.26 M(+294.6%) |
| Mar 2011 | - | $11.98 M(-69.5%) |
| Dec 2010 | $39.33 M(-28.3%) | $39.33 M(+395.5%) |
| Sept 2010 | - | $7.94 M(-82.7%) |
| June 2010 | - | $45.77 M(+37.0%) |
| Mar 2010 | - | $33.41 M(-39.1%) |
| Dec 2009 | $54.87 M(+120.8%) | $54.87 M(+113.4%) |
| Sept 2009 | - | $25.71 M(-53.6%) |
| June 2009 | - | $55.40 M(-25.3%) |
| Mar 2009 | - | $74.14 M(+198.3%) |
| Dec 2008 | $24.86 M(+32.1%) | $24.86 M(+76.7%) |
| Sept 2008 | - | $14.07 M(-37.3%) |
| June 2008 | - | $22.45 M(+4.3%) |
| Mar 2008 | - | $21.52 M(+14.4%) |
| Dec 2007 | $18.82 M(-56.6%) | $18.82 M(-55.2%) |
| Sept 2007 | - | $42.01 M(+116.6%) |
| June 2007 | - | $19.40 M(+392.9%) |
| Mar 2007 | - | $3.94 M(-90.9%) |
| Dec 2006 | $43.33 M(+1612.7%) | $43.33 M(+1223.9%) |
| Sept 2006 | - | $3.27 M(+29.4%) |
| Dec 2005 | $2.53 M(-86.4%) | $2.53 M(-86.4%) |
| Dec 2004 | $18.64 M | $18.64 M |
FAQ
- What is Emergent BioSolutions annual accounts receivable?
- What is the all time high annual accounts receivable for Emergent BioSolutions?
- What is Emergent BioSolutions annual accounts receivable year-on-year change?
- What is Emergent BioSolutions quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly accounts receivable year-on-year change?
What is Emergent BioSolutions annual accounts receivable?
The current annual accounts receivable of EBS is $141.80 M
What is the all time high annual accounts receivable for Emergent BioSolutions?
Emergent BioSolutions all-time high annual accounts receivable is $234.00 M
What is Emergent BioSolutions annual accounts receivable year-on-year change?
Over the past year, EBS annual accounts receivable has changed by +$39.10 M (+38.07%)
What is Emergent BioSolutions quarterly accounts receivable?
The current quarterly accounts receivable of EBS is $102.60 M
What is the all time high quarterly accounts receivable for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly accounts receivable is $251.40 M
What is Emergent BioSolutions quarterly accounts receivable year-on-year change?
Over the past year, EBS quarterly accounts receivable has changed by -$54.00 M (-34.48%)